Vector Science & Therapeutics expands patent portfolio to 15 applications

The TSXV-listed company said the filings built over about two years span peptide and biologic delivery, pain management, pancreatic oncology, regenerative medicine and smart wound care.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.